2 results
Approved WMOCompleted
To investigate the influence of concomitant enzalutamide on the pharmacokinetics of cabazitaxel.
Not approvedWill not start
The primary objective of this study is to explore the PSA response rate to cabazitaxel in mCRPC patients who have progressed to docetaxel and to correlate the PSA response to AR-V7 expression in CTCs. Exploratory objectives include documenting the…